Actively Recruiting
Primary Cardiac Lymphoma: Italian Multicenter Experience
Led by Fondazione Italiana Linfomi - ETS · Updated on 2026-01-05
43
Participants Needed
17
Research Sites
86 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The rationale of this study is to provide an overview on PCL (Primary Cardiac Lymphoma) in Italy, trying to shed light on unknown aspects of the disease and on unanswered questions about its management that could be helpful in clinical practice.
CONDITIONS
Official Title
Primary Cardiac Lymphoma: Italian Multicenter Experience
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Primary Cardiac Lymphoma (any type) involving only the heart, possibly with pericardium involvement
- Age 18 years or older
- Diagnosis confirmed by histology or cytofluorimetry of pericardial fluid showing features consistent with PCL
- Diagnosis date between January 1, 2000, and December 31, 2020
- First-line treatment with chemoimmunotherapy including an anti-CD20 monoclonal antibody
- Signed written informed consent
You will not qualify if you...
- Secondary cardiac involvement from lymphoma or primary mediastinal lymphoma with pericardial infiltration
- Other lymphomas involving the pericardium or heart by contiguity and primary effusion lymphoma
- Patients treated with chemotherapy regimens without an anti-CD20 monoclonal antibody as first-line therapy
- Refusal to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Presidio ospedaliero "A. TORTORA" - U.O. Onco-ematologia
Pagani, Salerno, Italy, 84016
Not Yet Recruiting
2
AOU di Sassari - Ematologia
Sassari, SS, Italy, 07100
Actively Recruiting
3
Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia
Trieste, TS, Italy, 34121
Actively Recruiting
4
Ospedale Dell'angelo - U.O. Ematologia
Mestre, Venezia, Italy, 30174
Not Yet Recruiting
5
Azienda Ospedaliera Papa Giovanni XXIII - Ematologia
Bergamo, Italy, 24127
Actively Recruiting
6
ASST Spedali Civili di Brescia - Ematologia
Brescia, Italy, 25123
Actively Recruiting
7
Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant'Anna - Ematologia e fisiopatologia della coagulazione
Ferrara, Italy, 44124
Actively Recruiting
8
Istituto Scientifico San Raffaele - Unitа Linfomi - Dipartimento Oncoematologia
Milan, Italy, 20132
Actively Recruiting
9
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Ematologia
Milan, Italy, 20133
Actively Recruiting
10
ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia
Milan, Italy, 20162
Actively Recruiting
11
Ospedale S. Maria della Misericordia - Ematologia
Perugia, Italy, 06129
Actively Recruiting
12
AOU Pisana - U.O. Ematologia
Pisa, Italy, 56126
Not Yet Recruiting
13
Roma - Universitа Cattolica S. Cuore - Ematologia
Roma, Italy, 00168
Not Yet Recruiting
14
AO Sant'Andrea - Ematologia
Roma, Italy, 00183
Actively Recruiting
15
A.O. S. Maria di Terni - S.C. Oncoematologia
Terni, Italy, 05100
Not Yet Recruiting
16
A.O.U. Città della Salute e della Scienza di Torino - Ematologia Universitaria
Torino, Italy, 10126
Not Yet Recruiting
17
AOU Integrata di Verona - U.O. Ematologia
Verona, Italy, 37134
Actively Recruiting
Research Team
G
Giorgio Priolo
CONTACT
S
Samantha Deianira Dattoli
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here